NEWS
October 23, 2009
Claude Perreault Honoured by the
Leukemia & Lymphoma Society of Canada
IRIC Investigator Receives the Murray Margarit Memorial Award in
Recognition of his Research in the Treatment of Leukemia
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is pleased to announce that one of its founding members, Dr. Claude Perreault, is the recipient of the 2009 Murray Margarit Memorial Award. The honour, granted today at an awards ceremony in held in Toronto by the Leukemia Lymphoma Society of Canada, recognizes the excellence of Dr. Perreault’s bone marrow transplant research in the treatment of leukemia.
Trained as a hematologist, Claude Perreault is a principal investigator at IRIC and full professor with the Université de Montréal Faculty of Medicine. In addition to his research and training work at IRIC, Perreault is a clinical practitioner at Maisonneuve-Rosemont Hospital. Perreault is a leader in research and implementation of new cancer treatments with a specific focus in the fields of bone marrow transplantation and cancer immunotherapy. His work has led to major advances in our understanding of graft-versus-host disease (GVHD), in the treatment of leukemia and in the development of a cancer vaccine.
The Murray Margarit Memorial Award is presented annually to one Leukemia and Lymphoma Society of Canada grant recipient in the form of a $120,000 two-year award. It is supported by the Margarit family in honour of Murray Margarit who was UFCW (Food and Commercial Workers) Canada’s head of leukemia research fundraising until 2005, when he died from complications of the blood cancer. Murray Margarit’s widow, Roxanne, and family hold an annual hockey game as a fundraiser to support this research award. Since adopting the Leukemia & Lymphoma Society of Canada as its charity of choice in 1985, members of UFCW Canada have raised almost $19.8 million for leukemia research.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Since the first funding in 1954, LLS has awarded more than $600 million in research funding. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org
Information
Carolyne Lord
Media Relations Officer
IRIC | Université de Montréal
514.343.7282
carolyne.lord@umontreal.ca
<< Back to News
